Long-Term Mortality and Morbidity at One Year among Universal Coverage (UC) Thai Patients Undergone Coronary Angiography without Further Cardiac Interventions (CAG Only) from 2020 - 2022

Authors

  • Panthep Khananuraksa National Health Security Office (NHSO), Thailand
  • Karoon Kuntiranont National Health Security Office (NHSO), Thailand
  • Damras Tresukosol The National Health Security Working Group for the Development of Diagnosis and Treatment of Coronary Artery Disease through Coronary Intervention, Thailand
  • Chumpol Piamsomboon The National Health Security Working Group for the Development of Diagnosis and Treatment of Coronary Artery Disease through Coronary Intervention, Thailand
  • Jitti Kositchaiwat The National Health Security Working Group for the Development of Diagnosis and Treatment of Coronary Artery Disease through Coronary Intervention, Thailand
  • Rachanid Pornvipavee National Health Security Office (NHSO), Thailand
  • Passaporn Charoensakulwong National Health Security Office (NHSO), Thailand
  • Kriddhiya Sriprasert National Health Security Office (NHSO), Thailand
  • Suphot Srimahachota The National Health Security Working Group for the Development of Diagnosis and Treatment of Coronary Artery Disease through Coronary Intervention, Thailand
  • Gumpanart Veerakul The National Health Security Working Group for the Development of Diagnosis and Treatment of Coronary Artery Disease through Coronary Intervention, Thailand
  • Chaiyos Kunanusont National Health Security Office (NHSO), Thailand

Keywords:

coronary angiography (CAG), CAG without further intervention (CAG only), ischemic heart disease, ischemic heart disease (IHD), cardiovascular disease (CVD), mortality, acute renal failure (ARF), acute stroke, long-term complication, National Health Security Office

Abstract

Coronary angiography (CAG) has been considered as a safe invasive procedure since it carries low mortality (<0.8%) and overall morbidity rates (<2.0%). Previously, our group reported a high short-term (in-hospital and 30 days) adverse events among 59,373 Thai patients underwent CAG Only from reimbursement data of the National Health Security Office (NHSO), Thailand 2016-2020, including death 2.90%, stroke 1.25% and acute kidney injury 7.50%. However, the claimed data did not provide clinical details to determine possible causes. Thus, NHSO had designed a short clinical data form to be filled up by service centers accompanying with reimbursement. However, low complications were reported from total CAG 5,019 cases, only 2.35% (95%CI 1.92, 2.78) including death, stroke, and acute renal failure (ARF) which 86.40% of them occurred within 24 hours of CAG Only suggestive of procedure-related events. Thus, we studied the long-term (from admission to one years) adverse clinical outcomes, including death, acute renal failure (ARF) and acute stroke, which had not been diagnosed before admission, of 53,300 patients underwent CAG Only (from total 141,605 CAG cases recorded) in the fiscal year 2020- 2023 of the NHSO system. It was found that proportion of CAG Only remained high, 37.63% (37.36-38.05%) among patients receiving CAG, and they carried a high in-hospital mortality rates of 2.6-2.7%. The highest mortality was observed in patients diagnosed with ischemic heart diseases (IHD), 7.15-8.06%, other cardiovascular diseases (CVD), 5.00-5.35%) and other diseases, 3.75-3.80%. Importantly, the mortality rates had increased by 1.5-1.7 times, from 7.5% (30 days) to 12.17% (one-year), accumulated to very high one-year mortality of 19.66% (18.71-20.22). We found relatively high rate of ARF, 4.24-5.37%, and acute stroke 1.05-1.28% which had not been diagnosed before admission. In addition, new diagnosis of ARF and acute stroke were re-admitted after CAG only, accumulated to the total average ARF of 9.54% and stroke of 3.46% which likely contributed to high one-year mortality. Conclusions: this analysis showed unacceptably high long-term mortality and morbidity of Thai patients undergone CAG Only. Although it could not be concluded as procedural related events but it should be a wake-up call for care providers, budget regulators and researchers, to improve case record details for risk factors, co-morbidities, to follow current practice standard guidelines and to provide preventive interventions for patient safety, hopefully to reduce unnecessary cost of these adverse events in the future.

Downloads

Download data is not yet available.

References

World Heart Federation. World Heart Observatory Country Profile – Thailand [Internet]. [cited 2024 Apr 2]. Available from: https://world-heart-federation.org/ world-heart-observatory/countries/thailand/

Veerakul G, Khajornhyai A, Wongkasai S, Srathongpim N, Noottaro A, Ketkaew J, et al. Predicting and preventing cardiovascular events in asymptomatic patients: a 10-year prospective study. BKK Med J 2017;13(1):1- 12.

Tavakol M, Ashraf S, Brenner SJ. Risks and complications of coronary angiography: a comprehensive review. Global J Health Science 2012;4(1):65-93.

Al-Hijji MA, Lennon R, Gulat R. Safety and risk of major complications with diagnostic cardiac catheterization. Circ Cardiovasc Interv 2019;12:e007791.

Dehmer GJ, Weaver D, Roe MT, Milford-Beland S, Fitzgerald S, Hermann A, et al. A contemporary view of diagnostic cardiac catheterization and percutaneous coronary intervention in the United States: a report from the CathPCI Registry of the National Cardiovascular Data Registry, 2010 through June 2011. J Am Coll Cardiol 2012;60:2017–31.

ปานเทพ คณานุรักษ์, ชุมพล เปี่ยมสมบูรณ์, จิตติ โฆษิต ชัยวัฒน์, รัชนิศ พรวิภาวี, กัมปนาท วีรกุล. อัตราตายและ ภาวะแทรกซ้อนที่สูงจากการตรวจวินิจฉัยโรคหลอดเลือด โคโรนารีผ่านสายสวนโดยไม่มีหัตถการต่อเนื่อง: ผลการ ศึกษาข้อมูลการขอเบิกย้อนหลังในระบบหลักประกันสุขภาพ แห่งชาติ (พ.ศ. 2559-2563). วารสารวิชาการสาธารณสุข 2565;31(2):328-35.

อภิสมัย สวัสดิสาร, ปริยาภรณ์ มณีแดง, มาลีรัตน์ งามจิตต์เอื้อ, ปราโมทย์วงศ์ประสาร, ชัยยศ คุณานุสนธิ์. รายงานการ วิเคราะห์ข้อมูล one-page CAG registry เดือนพฤษภาคม พ.ศ. 2565. กรุงเทพมหานคร: สำนักงานหลักประกันสุขภาพ แห่งชาติ; 2565.

Falk E, Nakano M, Bentzon JF, Finn AV, Virmani R. Update on acute coronary syndromes: the pathologists’ view. Eur Heart J 2013;34(10):719-28.

Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000;20:1262-75.

Maddox TM, Stanislawski MA, Grunwald JK, Bradley SM, Ho M, Tsai TT, et al. Non-obstructive coronary artery disease and risk of myocardial infarction. JAMA 2014;312(17):1754–63.

Cholesterol Treatment Trialists’ (CTT) Collaboration, Baigent C, Blackwell L, Emberson J, Holland LE, Reith C, et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 2010;376(9753):1670-81.

Esselstyn CB Jr. Resolving the coronary artery disease epidemic through plant-based nutrition. Prev Cardiol 2001;4(4):171-7.

Veerakul G, Kitkungvan T, Bhatia N. Improved angiographic findings in a high-risk acute coronary syndrome patient after modest weight reduction, regular exercise and medication: A case report and literature review. Bangkok Medical Journal 2012;4(1):50-6.

Gould KL, Ornish D, Kirkeeide R, Brown S, Stuart Y, Buchi M, et al. Improve stenosis geometry by quantitative coronary arteriography after vigorous risk factor modification. Am J Cardiol 1992;69(9):845-53.

Jensen LO, Thayssen P, Pedersen KE, Stender S, Haghfelt T. Regression of coronary atherosclerosis by simvastatin: a serial intravascular ultrasound study. Circulation 2004;110(3):265-70.

Nissen SE, Nichols SJ, Sipahi I, Libby P, Raichlen JS, Ballantyne CM, et al. Effect of intensive compared with moderate lipid lowering therapy on progression of coronary atherosclerosis: the ASTEROID trial. JAMA 2006; 295(13):1556-65.

Nicholls SJ, Ballantyne CM, Barter PJ, Chapman MJ, Erbel RM, Libby P, et al. Effect of Two Intensive Statin Regimens on Progression of Coronary Disease. N Engl J Med 2011; 365(22):2078-87.

Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, B€ ack M, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies with the special contribution of the European Association of Preventive Cardiology (EAPC). Eur Heart J 2021;42:3227-37.

Chaulin AM. False-positive causes in serum cardiac troponin levels. J Clin Med Res. 2022;14(2):80-7.

Scalon PJ, Faxon DP, Audet AM, Dehmer GJ, Eagle KA, Regako RD, et al. ACC/AHA guidelines for coronary angiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography). Developed in collaboration with the Society for Cardiac Angiography and Interventions. J Am Coll Cardiol 1999;33(6):1756-824.

Naidu S, Abbott JD, Bagai J, Blankenship J, Garcia S, Iqbal SN, et al. SCAI expert consensus update on best practices in the cardiac catheterization laboratory, endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), and the Heart Rhythm Society (HRS) in April 2021. Catheter Cardiovasc Interv 2021;98:255–76.

สมาคมแพทย์โรคหัวใจแห่งประเทศไทย. แนวเวชปฏิบัติการ ดูแลรักษาผู้ป่วยภาวะหัวใจขาดเลือดเฉียบพลัน พ.ศ. 2563 (Thai Acute Coronary Syndromes Guidelines 2020). กรุงเทพมหานคร: เนคสเตปดีไซน; 2563.

สมาคมแพทย์โรคหัวใจแห่งประเทศไทย. แนวเวชปฏิบัติการ ดูแลรักษาผู้ป่วยภาวะหัวใจขาดเลือดเรื้อรัง พ.ศ. 2564 (Thai Chronic Coronary Syndrome Guidelines 2021). กรุงเทพมหานคร: เนคสเตปดีไซน; 2565.

Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM, Bischoff JM, et al. 2021 ACC/AHA/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guideline. Circulation 2022;145(3):e18–e114.

Published

2024-06-30

How to Cite

คณานุรักษ์ ป., คุณติรานนท์ ก., ตรีสุโกศล ด., เปี่ยมสมบูรณ์ ช., โฆษิตชัยวัฒน์ จ., พรวิภาวี ร., เจริญสกุลวงค์ พ., ศรีประเสริฐ ก., ศรีมหาโชตะ ส., วีรกุล ก., & คุณานุสนธิ์ ช. (2024). Long-Term Mortality and Morbidity at One Year among Universal Coverage (UC) Thai Patients Undergone Coronary Angiography without Further Cardiac Interventions (CAG Only) from 2020 - 2022 . Journal of Health Science of Thailand, 33(3), 505–516. Retrieved from https://www.thaidj.org/index.php/JHS/article/view/15212

Issue

Section

Original Article (นิพนธ์ต้นฉบับ)